053030 — Binex Share Price
- KR₩197bn
- KR₩284bn
- KR₩168bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 26.35 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.22 | ||
| Price to Tang. Book | 1.37 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.25 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -10.72% | ||
| Return on Equity | -16.86% | ||
| Operating Margin | -15.4% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 134,399.28 | 156,677.02 | 154,824.78 | 130,050.55 | 168,474.91 | 171,479 | 208,549 | 4.85% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +156.16 | -32.97 | -85.79 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Binex Co Ltd is a Korea-based company engaged in the manufacture and sale of chemical pharmaceuticals and the contract manufacturing of biopharmaceuticals. The Company operates its business through two segments. The Pharmaceutical Business segment is engaged in the manufacture and sale of chemical pharmaceutical products. The Biopharmaceutical Business segment is engaged in the contract manufacturing of active pharmaceutical ingredients and finished biopharmaceutical products, as well as the provision of analytical testing services.
Directors
- Baek Cheon Lee CHM (71)
- Hyeok Jong Lee CEO (45)
- Du Hyeon Kim VPR (60)
- Jun Seok Park MDR (68)
- Su Yong Jin OTH (45)
- Myeong Cheol Lee OTH (54)
- Noboru Inaska OTH (57)
- Myeong Ho Jeon DRC (42)
- Taizan Kawakami DRC (64)
- Shigeki Yamauchi DRC (60)
- Takahiro Yoshikawa DRC (69)
- Yun Ok Choi NID (35)
- Yin Yeong Oh NID (47)
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- June 5th, 1985
- Public Since
- August 7th, 2001
- No. of Shareholders
- 52,896
- No. of Employees
- 390
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Korea Exchange - KOSDAQ
- Shares in Issue
- 31,847,676

- Address
- 368-3, Dadae-Ro, Saha-Gu, BUSAN, 49469
- Web
- https://www.bi-nex.com/
- Phone
- +82 512616611
- Auditors
- Daejoo Accounting Corp.
Latest News for 053030
Upcoming Events for 053030
Q3 2026 Binex Co Ltd Earnings Release
Q4 2026 Binex Co Ltd Earnings Release
Binex Co Ltd Annual Shareholders Meeting
Similar to 053030
AbClon
Korea Exchange - KOSDAQ
ADBiotech
Korea Exchange - KOSDAQ
AHN-GOOK PHARMACEUTICAL
Korea Exchange - KOSDAQ
Alteogen
Korea Exchange - KOSDAQ
AMINOLOGICS
Korea Exchange - KOSDAQ
FAQ
As of Today at 19:36 UTC, shares in Binex are trading at KR₩6,170. This share price information is delayed by 15 minutes.
Shares in Binex last closed at KR₩6,170 and the price had moved by -60.81% over the past 365 days. In terms of relative price strength the Binex share price has underperformed the FTSE Developed Asia Pacific Index by -70.9% over the past year.
The overall consensus recommendation for Binex is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreBinex does not currently pay a dividend.
Binex does not currently pay a dividend.
Binex does not currently pay a dividend.
To buy shares in Binex you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩6,170, shares in Binex had a market capitalisation of KR₩197bn.
Here are the trading details for Binex:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 053030
Based on an overall assessment of its quality, value and momentum Binex is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Binex is KR₩12,150. That is 96.92% above the last closing price of KR₩6,170.
Analysts covering Binex currently have a consensus Earnings Per Share (EPS) forecast of -KR₩84 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Binex. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -46.7%.
As of the last closing price of KR₩6,170, shares in Binex were trading -37.69% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Binex PE ratio based on its reported earnings over the past 12 months is 26.35. The shares last closed at KR₩6,170.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Binex's management team is headed by:
- Baek Cheon Lee - CHM
- Hyeok Jong Lee - CEO
- Du Hyeon Kim - VPR
- Jun Seok Park - MDR
- Su Yong Jin - OTH
- Myeong Cheol Lee - OTH
- Noboru Inaska - OTH
- Myeong Ho Jeon - DRC
- Taizan Kawakami - DRC
- Shigeki Yamauchi - DRC
- Takahiro Yoshikawa - DRC
- Yun Ok Choi - NID
- Yin Yeong Oh - NID





